Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
12.19 CHF | -0.08% | -0.89% | -1.85% |
Mar. 19 | International Flavors & Fragrances Sells Pharma Solutions for $2.85 Billion Value to Roquette | MT |
Mar. 07 | CLARIANT : 'an attractive entry point' according to UBS | CF |
Sales 2024 * | 4.33B 4.8B | Sales 2025 * | 4.54B 5.03B | Capitalization | 4.01B 4.44B |
---|---|---|---|---|---|
Net income 2024 * | 241M 267M | Net income 2025 * | 306M 339M | EV / Sales 2024 * | 1.29 x |
Net Debt 2024 * | 1.57B 1.74B | Net Debt 2025 * | 1.52B 1.68B | EV / Sales 2025 * | 1.22 x |
P/E ratio 2024 * |
16.6
x | P/E ratio 2025 * |
13
x | Employees | 10,481 |
Yield 2024 * |
3.66% | Yield 2025 * |
4.01% | Free-Float | 62.21% |
Latest transcript on Clariant AG
1 day | -0.08% | ||
1 week | -0.89% | ||
Current month | +11.43% | ||
1 month | +9.82% | ||
3 months | -1.85% | ||
6 months | -14.22% | ||
Current year | -1.85% |
Managers | Title | Age | Since |
---|---|---|---|
Conrad Keijzer
CEO | Chief Executive Officer | 55 | 20-12-08 |
Bill Collins
DFI | Director of Finance/CFO | - | 22-06-30 |
Chief Tech/Sci/R&D Officer | - | 22-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Geoffery Merszei
BRD | Director/Board Member | 73 | 18-10-15 |
Director/Board Member | 69 | 20-06-28 | |
Peter Steiner
BRD | Director/Board Member | 64 | 16-04-20 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.40% | 144 M€ | +4.93% | - | |
0.39% | 2 M€ | -.--% | - | |
0.39% | 2 M€ | +9.19% | - | |
0.33% | 176 M€ | +7.03% | ||
0.13% | 18 M€ | +6.77% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-28 | 12.19 | -0.08% | 832,039 |
24-03-27 | 12.2 | +1.33% | 1,130,990 |
24-03-26 | 12.04 | -1.71% | 771,020 |
24-03-25 | 12.25 | -0.41% | 625,706 |
24-03-22 | 12.3 | 0.00% | 945,819 |
Delayed Quote Swiss Exchange, March 28, 2024 at 12:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.85% | 4.45B | |
+16.41% | 66.02B | |
-1.86% | 47.84B | |
+15.27% | 41.14B | |
+1.62% | 17.97B | |
+11.35% | 16.75B | |
-8.82% | 15.48B | |
+30.62% | 12.91B | |
-0.95% | 9.22B | |
-2.93% | 8.65B |